- CYCC Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-Q/A Filing
Cyclacel Pharmaceuticals (CYCC) 10-Q/A2006 Q1 Quarterly report (amended)
Filed: 7 Jul 06, 12:00am
EXHIBIT 32.2
Certification of Executive Vice President, Finance
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Cyclacel Pharmaceuticals, Inc. (the ‘‘Company’’) hereby certifies, to such officer’s knowledge, that:
(i) the accompanying Quarterly Report on Form 10-Q/A of the Company for the quarterly period ended March 31, 2006 (the ‘‘Report’’) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: July 7, 2006 | /s/ Paul McBarron | ||
Paul McBarron Chief Operating Officer and Executive Vice President, Finance | |||